Hofseth Biocare ASA: Key Information regarding the subsequent offering in Hofseth BioCare ASA
September 19 2016 - 9:08AM
Date when the conditions for
the share capital increase will be announced: 20 September
2016
Last day of trading in the Shares incl. Allocation Rights: 20
September 2016
First day of trading in the Shares excl. Allocation Rights: 21
September 2016
Record Date: 22 September 2016
Resolution date: 20 September 2016
Maximum number of new shares: 13,333,334
Subscription price: NOK 1.50
For further information,
please contact:
Jon Olav Ødegård, CFO of
Hofseth BioCare ASA
Mob: +47 936 32 966
E-mail: joo@hofsethbiocare.no
About Hofseth BioCare
ASA:
HBC is a Norwegian biotech
company that offers high-value ingredients and finished products
for humans and pets. The company is founded on the core values of
sustainability, traceability and optimal utilization of natural
resources. Through an innovative hydrolysis technology, HBC is able
to preserve the quality of salmon oil, proteins and calcium,
prepared of fresh salmon off-cuts. HBC's objective is to contribute
to the efficient use of marine resources and deliver quality
products for ingredients and finished consumer products in the
nutrition market.
Hofseth BioCare's
headquarters are located in Ålesund, Norway with branches in Oslo,
Chicago, Mumbai and Tokyo. HBC is listed on Oslo Stock Exchange
Axess list with ticker "HBC". More information about Hofseth
BioCare at www.hofsethbiocare.com and
www.facebook.com/hofsethbiocare
This information is subject to the disclosure requirements pursuant
to section 5-12 of the Norwegian Securities Trading Act.
This
announcement is distributed by Nasdaq Corporate Solutions on behalf
of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely
responsible for the content, accuracy and originality of the
information contained therein.
Source: Hofseth Biocare ASA via Globenewswire